Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1986 Jun;43(6):387–390. doi: 10.1136/oem.43.6.387

Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.

L R Cook, C R Angle, S J Stohs
PMCID: PMC1007668  PMID: 3013277

Abstract

The activities of three erythrocyte (rbc) enzymes, arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N), were compared in 16 lead workers and 14 age matched controls as correlates of blood lead (PbB) and unextracted zinc protoporphyrin (EP) concentrations. Subjects with PbB of 0.9-2.5 microM (19-52 micrograms/dl) had 6.5 +/- 0.6 IU of P5N activity with uridine monophosphate (UMP) as substrate, significantly less (p less than 0.001) than the 12.0 +/- 0.7 IU activity of controls with PbB 0.3-0.6 microM (6-12 micrograms/dl). The mean activity of rbc dP5N with either deoxyuridine monophosphate (dUMP) or thymidine monophosphate as substrate, and of rbc arginase, did not differentiate the two groups. The correlation coefficients of ln PbB with the selected substrates for P5N and dP5N were: UMP, r = -0.75; dUMP, r = -0.61; TMP, r = -0.23. The correlation coefficient of ln PbB and arginase activity was -0.03. Rbc P5N (UMPase) is a significant correlate of PbB, equivalent to rbc protoporphyrin. HPLC assay of rbc UMPase activity is a sensitive and rapid assay that appears to meet criteria for a reliable clinical laboratory index of blood lead concentrations.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angle C. R., McIntire M. S. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase. Environ Res. 1978 Oct;17(2):296–302. doi: 10.1016/0013-9351(78)90032-4. [DOI] [PubMed] [Google Scholar]
  2. Beutler E., West C., Blume K. G. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976 Aug;88(2):328–333. [PubMed] [Google Scholar]
  3. Buc H. A., Kaplan J. C. Red-cell pyrimidine 5'-nucleotidase and lead poisoning. Clin Chim Acta. 1978 Jul 1;87(1):49–55. doi: 10.1016/0009-8981(78)90056-6. [DOI] [PubMed] [Google Scholar]
  4. Chmielnicka J., Komsta-Szumska E., Szymańska J. A. Arginase and kallikrein activities as biochemical indices of occupational exposure to lead. Br J Ind Med. 1981 May;38(2):175–178. doi: 10.1136/oem.38.2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cook L., Schafer-Mitchell M., Angle C., Stohs S. Assay of human erythrocyte pyrimidine and deoxypyrimidine 5'-nucleotidase by isocratic reversed-phase high-performance liquid chromatography. J Chromatogr. 1985 May 3;339(2):293–301. doi: 10.1016/s0378-4347(00)84656-3. [DOI] [PubMed] [Google Scholar]
  6. Despaux-Pages N., Comoy E., Bohuon C., Boudene C. Immunoturbidimetric assay of delta aminolevulinic acid dehydratase (ALA D) on a centrifugal fast analyser. Clin Chim Acta. 1985 Apr 15;147(2):179–181. doi: 10.1016/0009-8981(85)90080-4. [DOI] [PubMed] [Google Scholar]
  7. Fukumoto K., Karai I., Nishikawa Y., Horiguchi S. Erythrocyte arginase activity as an indicator of lead exposure. Br J Ind Med. 1983 Feb;40(1):106–110. doi: 10.1136/oem.40.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mohammed-Brahim B., Buchet J. P., Bernard A., Lauwerys R. In vitro effects of lead, mercury and cadmium on the enzymic activity of red-blood cell pyrimidine 5'-nucleotidase. Toxicol Lett. 1984 Feb;20(2):195–199. doi: 10.1016/0378-4274(84)90147-4. [DOI] [PubMed] [Google Scholar]
  9. Orfanos A. P., Naylor E. W., Guthrie R. Fluorometric micromethod for determination of arginase activity in dried blood spots on filter paper. Clin Chem. 1980 Jul;26(8):1198–1200. [PubMed] [Google Scholar]
  10. Paglia D. E., Valentine W. N., Fink K. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides. J Clin Invest. 1977 Dec;60(6):1362–1366. doi: 10.1172/JCI108896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rocco R. M., Smart J. L., Brown D. R., Blumberg J. B. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead. Res Commun Chem Pathol Pharmacol. 1981 Oct;34(1):127–136. [PubMed] [Google Scholar]
  12. Tomokuni K., Ogata M. Relationship between lead concentration in blood and the activities of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the mice exposed to lead. Arch Toxicol. 1981 Mar;47(1):67–69. doi: 10.1007/BF00297133. [DOI] [PubMed] [Google Scholar]
  13. Torrance J. D., Mills W., Kilroe-Smith T. A., Smith A. N. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure. S Afr Med J. 1985 May 25;67(21):850–852. [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES